Sealantium Medical

Tissue Sealants and Hemostatic Agents

Health Tech & Life Sciences
Active
Series B Rosh Haayin, Israel Founded 2011
Last updated 2026-06-18
Total raised
$11.6M
Last: 2018-10
Stage
Series B
Founded
2011
Headcount
6
HQ
Rosh Haayin, Israel
Sector
Health Tech & Life Sciences

About

Sealantium Medical is a biosurgery company focused on the development of proprietary next generation tissue sealants and hemostatic agents for patients undergoing surgery.

The company's flagship product is the sFilm-FS™, which comprises a biodegradable and biocompatible, non-permeable polymeric film containing Fibrin Sealant. This polymeric film uniquely enables sealing capabilities alongside accelerating fluid coagulation and site adhesion. As a result of this novel mechanism of action, substantially less Fibrin Sealant is needed lowering costs and accelerating speed of sealing (2min) for improved performance.

Successful preclinical data has demonstrated efficacy and usability of the sFilm-FS. Promising early clinical results show safety and a faster performance in controlling liver bleeding during surgery than the market leading product.

Funding history · 2 rounds · $11.6M total

2018-04
Grant $1.6M

Q&A

What is Sealantium Medical's primary focus?
Sealantium Medical is a biosurgery company that develops proprietary next-generation tissue sealants and hemostatic agents for surgical patients.
What is Sealantium Medical's flagship product?
The company's flagship product is sFilm-FS™, a biodegradable and biocompatible polymeric film containing Fibrin Sealant, designed to accelerate fluid coagulation and site adhesion during surgery.
What is the current employee count for Sealantium Medical?
Sealantium Medical has 1-10 employees.
When was Sealantium Medical founded?
Sealantium Medical was founded in January 2011.
What is the total amount of funding Sealantium Medical has raised to date?
Sealantium Medical has raised a total of $11,572,319.
When was Sealantium Medical's most recent funding round and who were the lead investors?
Sealantium Medical's most recent funding round occurred in October 2018, with Biotech Alliances International as the lead investor.
What is Sealantium Medical's current funding stage?
Sealantium Medical is currently in its Series B funding stage.
Who is the founder and CEO of Sealantium Medical?
Orgad Laub is the Founder & CEO of Sealantium Medical.

Team · 1

Founder · Founder & CEO
LinkedIn ↗

Sectors & technology

Primary sector
Health Tech & Life Sciences
Sub-sectors
Health Tech & Life SciencesPharma & Medical BiotechnologyBiomaterials & Tissue Engineering
Technologies
Materials & SubstancesPolymers
Target customers
Healthcare & Life SciencesHealthcareProviders
Business model
B2B

Highlights

1 PatentsVerified

Tags

first-aidmedical-technologiessurgerybiotechnologybiodegradablepolymershospitalscritical-caretissue-regeneration
Full data — links, identifiers, deals & radar signals (jobs, patents, research, more)